<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Health and Population Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F516F19F-4A76-4D17-81D5-B9D970CB3B37"><gtr:id>F516F19F-4A76-4D17-81D5-B9D970CB3B37</gtr:id><gtr:firstName>Hareth</gtr:firstName><gtr:surname>Al-Janabi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002334"><gtr:id>ED2EAE80-5F61-44AF-AB8E-D52A750A51F7</gtr:id><gtr:title>Measuring and modelling the 'spillover' effects of healthcare interventions</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1002334</gtr:grantReference><gtr:abstractText>Decisions about the funding of new healthcare treatments depend on the health benefits of the treatment. In decision-making it is common to focus only on benefits to the patients, however this neglects any knock on impact that treatments may have on the lives of those close to patients. Improvements in a patient?s health may, for example, relieve family members of stressful caring tasks and reduce their anxiety about their loved one?s health. 

The proposed research will study whether poor patient health has a knock-on impact on unpaid carers (normally family members). Data from studies of carers of patients with Parkinson?s disease and carers of children who have survived meningitis will be used investigate any link between patients? health and carers? health and wellbeing. Research will be carried out to investigate whether it is caring per se or whether it is the poor health of a loved one that affects carers? health the most. Ultimately the research findings will be used to develop a way of predicting the likely knock-on health impacts on carers in different situations so that these can be considered in healthcare funding decisions.</gtr:abstractText><gtr:technicalSummary>Aim
To estimate the ?spillover? impact of the patient?s health condition on unpaid carers and to develop econometric models to forecast these impacts for use in economic evaluation.

Objectives
Phase 1: Validation of outcome instruments to measure the spillover impact in carers.
Phase 2: Measurement of the extent of spillover impacts on carers using trial and survey data.
Phase 3: Disentangling the spillover impact to distinguish between the ?caring? and ?family? effect.
Phase 4: Econometric modelling of spillover impacts for future use in economic evaluation.

Design/Methodology
Phase 1: Tests of the validity and sensitivity of a new measure of ?care-related? quality of life (the Carer Experience Scale) will be conducted using existing survey data from the UK, Australia and the Netherlands and data from a trial of drugs for Parkinson?s disease (PD trial).

Phase 2: Longitudinal data on outcomes for carers in the PD trial and carers of meningitis survivors (MEN study) will be collected using standardised instruments. The data will be used to explore how spillover impacts differ by illness, patient health state and hours of care provided. The analysis will be extended, where possible, by incorporating carer outcome data from other studies and outcome data for non-caring family members.

Phase 3: Data from the MEN study will be used to identify the degree to which carer health is affected by the caring tasks undertaken as opposed to the patient?s health condition. These ?caring? and ?family? effects will be estimated using regression models with the carer?s health (and wellbeing in the second model) as the dependent variable and patient health, the number of caring tasks and other contextual characteristics of the caring situation as independent variables.
 
Phase 4: Econometric modelling will be used to develop predictive models of the spillover effects of poor patient health. Data will be synthesised from different soue regression models with the carer?s quality-adjusted life year (QALY) change as the dependent variable and a range of variables such as patient QALY change, hours of care and nature of patient disease as independent variables. 

Scientific and medical opportunities
By identifying spillover effects and developing regression models to forecast these, this research will promote: (i) improved adherence to economic evaluation guidelines and (ii) decisions that come closer to maximising health benefits from available resources. This work will further explore the potential for using econometrics to estimate spillover impacts for economic evaluation.</gtr:technicalSummary><gtr:fund><gtr:end>2014-06-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-06-04</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>276684</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>British Science Festival workshop (Birmingham)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>61DF19F2-EEDC-4768-B8E1-3EB17F1AD77A</gtr:id><gtr:impact>20 members of the public attented a 1-hour interactive workshop on healthcare funding. The audience participated through using turning point voting software. The workshop sparked questions and discussion afterwards.

None as yet - the workshop was held last month.</gtr:impact><gtr:outcomeId>544f5b3ee3d394.04760631</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 5 interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C0A0AB71-9755-4BD4-A228-CC2D0C7A4720</gtr:id><gtr:impact>I spoke on national radio show (reach 1.7m listeners) about research into the family impact of meningitis. I participated as part of a panel, alongside a clinican and charity representative, discussing the funding of a new vaccine for meningitis.

The UK government advisory body (the joint committees on vaccination and infection) reversed an ealier negative recommendation, and advised the government to fund the meningitis vaccine. To what extent - if any - this can be attributed to the interview is not clear.</gtr:impact><gtr:outcomeId>544f5d05ce85d7.80766172</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4662</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel project grant</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M025179/1</gtr:fundingRef><gtr:id>21F63E61-D9BB-406C-A28A-9EF7975CB083</gtr:id><gtr:outcomeId>58ad98e71d2ff8.40570309</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>116000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Birmingham Fellowship</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>University of Birmingham</gtr:fundingOrg><gtr:id>5BD82224-1B7A-4CD4-8CF0-1FEE9B38F299</gtr:id><gtr:outcomeId>RrW8FdRhcyo</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>585075</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Fellowship Programme</gtr:department><gtr:description>National Institute for Health Career Development Fellowship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>CDF-2015-08-025</gtr:fundingRef><gtr:id>6613EBC0-F6F8-44EA-BE91-A525A6D40C7E</gtr:id><gtr:outcomeId>58ab1211316ed9.12548990</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MDS College doctoral studentship competition</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University of Birmingham</gtr:fundingOrg><gtr:id>88D1625C-55E6-4904-9C31-AEC5A40E67BB</gtr:id><gtr:outcomeId>h8Riawc5itb</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sexually Transmitted Infections Research Foundation - research grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Sexually Transmitted Infection Research Foundation (STIRF)</gtr:fundingOrg><gtr:fundingRef>STIRF 031</gtr:fundingRef><gtr:id>8EA6FC08-19AE-44E3-BEA1-886204949767</gtr:id><gtr:outcomeId>56cedb88cd0322.57890640</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Meningitis Research Foundation - research grants</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Meningitis Research Foundation</gtr:fundingOrg><gtr:fundingRef>Project 1506.0</gtr:fundingRef><gtr:id>D6C0DFC8-2672-40DF-A53B-6ED261CC7875</gtr:id><gtr:outcomeId>56cedd4c6c4044.42283640</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small Research Grants</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>The British Academy</gtr:fundingOrg><gtr:fundingRef>SG141308</gtr:fundingRef><gtr:id>C3F43671-DF66-4AFC-8E76-EBEF271DF380</gtr:id><gtr:outcomeId>56cedc4ddaa963.38268739</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence cited in JCVI decision on Bexsero funding</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>772302DE-2AD0-48E3-AA23-0DE179C57B10</gtr:id><gtr:outcomeId>GgK6x7nPcEy</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Policy commission on healthy ageing</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83A1F34F-AE7E-4F12-9268-01D3B25EC017</gtr:id><gtr:outcomeId>M53ovAd5BNk</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence cited in JCVI reversal on Bexsero funding</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44F7F71F-2135-4E3A-B675-6CC0DC6F2361</gtr:id><gtr:outcomeId>544f5f9cb75a21.69306498</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participant in NICE Social Care workshop</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9B6D10A4-E79C-422B-94D8-1B347E05EBFB</gtr:id><gtr:outcomeId>nCRQ8r9Gbcx</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Database of quality of life and caring responsibilities of c. 1200 families affected by meningitis.</gtr:description><gtr:id>68CD340C-42AD-4159-A0E3-CEF5B750C074</gtr:id><gtr:impact>The dataset has been used (within the University of Birmingham) to address additional research questions about the measurement of quality of life in families affected by ill health. Two manuscripts have been accepted subject to minor revisions.</gtr:impact><gtr:outcomeId>58ad9c3397acb3.49370320</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Family impact of meningitis dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3567AA69-010B-4F34-973B-F5DEB0D18695</gtr:id><gtr:title>An investigation into the construct validity of the Carer Experience Scale (CES).</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7c3905c82cd06d10dce17731b3b9f2e"><gtr:id>a7c3905c82cd06d10dce17731b3b9f2e</gtr:id><gtr:otherNames>Goranitis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>544f599fc8a806.19182624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F920A930-067F-446E-9E46-89405B740C35</gtr:id><gtr:title>Predicting carer health effects for use in economic evaluation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fd65c9be7e5.48151985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1D5904A-0500-4624-82E9-A522FE3299A7</gtr:id><gtr:title>QALYs and carers.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>pm_15279_29_22077576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AFEB52E-9B81-4AA5-B587-38EE09E2CEA2</gtr:id><gtr:title>Informal care: choice or constraint?</gtr:title><gtr:parentPublicationTitle>Scandinavian journal of caring sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0283-9318</gtr:issn><gtr:outcomeId>5a2fd781680ab1.77054084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B05F2B7-7027-463A-B839-02F7A60C4741</gtr:id><gtr:title>Carer preferences in economic evaluation and healthcare decision making.</gtr:title><gtr:parentPublicationTitle>The patient</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1178-1653</gtr:issn><gtr:outcomeId>pm_540e178e1784b8f66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ECFD7AA-3E9C-4663-8CC1-BC445453AEBC</gtr:id><gtr:title>A Framework for Including Family Health Spillovers in Economic Evaluation.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56ced9daa85d76.16415707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>681212EE-5B9D-4364-A791-6CF0322ABF11</gtr:id><gtr:title>The inclusion of informal care in applied economic evaluation: a review.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5209208c21b00c8517beb190effd65"><gtr:id>5b5209208c21b00c8517beb190effd65</gtr:id><gtr:otherNames>Goodrich K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pm_15279_29_22999150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF1649C7-D857-4C85-A535-0D75A99D65B1</gtr:id><gtr:title>Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1318053d75ce0807bb3ef7838aabc83"><gtr:id>e1318053d75ce0807bb3ef7838aabc83</gtr:id><gtr:otherNames>Al-Janabi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>56ced9db062370.71519028</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002334</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>712BA5B2-EB41-48F7-A933-F9EFA1D3314B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>7.1  Individual care needs</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>237CBF0D-6B87-46FD-A97B-E432D87D3FE6</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>8.2  Health and welfare economics</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>